Related Experiment Videos
Intraventricular electrogram mapping and radiofrequency cardiac ablation for ventricular tachycardia
1EP Technologies, Boston Scientific Company, Sunnyvale, CA 94086, USA.
Physiological Measurement
|February 1, 1997
Summary
Radiofrequency catheter ablation is increasingly used for cardiac arrhythmias. For ventricular tachycardia, improved mapping and ablation tools enhance success rates, particularly for specific patient groups.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Radiofrequency catheter ablation has become a primary therapy for cardiac rhythm disorders since the 1980s.
- Ventricular tachycardia (VT) treatment is a significant focus in cardiac electrophysiology.
- Advancements in technology have driven the adoption and efficacy of ablation procedures.
Purpose of the Study:
- To review the fundamentals of cardiac mapping and radiofrequency ablation for ventricular tachycardia.
- To assess the clinical utility and evolving role of radiofrequency ablation in treating VT.
- To identify current limitations and future directions for improving VT ablation outcomes.
Main Methods:
- Review of existing literature on cardiac mapping and radiofrequency ablation techniques.
- Analysis of clinical data regarding the success and complication rates of VT ablation.
- Evaluation of technological advancements in mapping systems and ablation devices.
Main Results:
- Radiofrequency ablation for VT has seen consistent growth in utilization.
- High success and low complication rates are currently achieved in specific VT types (bundle branch, idiopathic, monomorphic, stable).
- Outcomes for VT related to coronary artery disease remain suboptimal with current technologies.
Conclusions:
- Radiofrequency ablation is an established and growing treatment for VT.
- Further technological innovation is required to improve ablation efficacy for complex VT, especially in coronary artery disease patients.
- Enhanced mapping accuracy and larger lesion creation devices are crucial for future success rates.